AbbVie Inc. (NYSE:ABBV)

The financial performance from 2021 to 2025 is characterized by a period of significant volatility in value creation, transitioning from substantial economic profit to a period of value destruction, followed by a recovery to positive economic profit.

Net Operating Profit After Taxes (NOPAT)

A sharp contraction is observed between 2021 and 2023, where NOPAT fell from 12,362 million to 3,292 million. This precipitous decline indicates a substantial reduction in operational profitability during this window. A recovery trend emerged in 2024 and 2025, with values rising to 4,563 million and 5,919 million, respectively, although levels remained well below the 2021 baseline.

Cost of Capital

The cost of capital exhibited a consistent upward trajectory throughout the analyzed period, increasing from 7.83% in 2021 to 8.71% in 2025. This steady rise represents an increasing hurdle rate, making it more challenging for the organization to generate positive economic profit from its invested capital.

Invested Capital

A general downward trend in invested capital is evident, decreasing from 95,922 million in 2021 to 61,356 million in 2025. Aside from a slight increase in 2024, the continuous reduction in the capital base suggests a strategic downsizing or a significant reduction in asset utilization over the five-year period.

Economic Profit

Economic profit transitioned from a state of value creation in 2021 and 2022, with figures of 4,853 million and 4,680 million, to value destruction in 2023 and 2024, reaching a low of -2,535 million. This negative trend was primarily driven by the collapse in NOPAT, which outweighed the benefits of a reduced capital base. By 2025, the company returned to a positive economic profit of 574 million, signaling a return to creating value above the cost of capital.

Net earnings attributable to AbbVie Inc. exhibited an initial increase from 2021 to 2022, followed by a substantial decline in 2023 and a slight recovery in 2024 and 2025. However, the trend in net operating profit after taxes (NOPAT) presents a different pattern. NOPAT decreased from 2021 to 2023, then increased significantly in 2024 and 2025.

NOPAT Trend

NOPAT began at US$12,362 million in 2021, decreasing to US$11,543 million in 2022, representing a decline of approximately 6.7%. A more pronounced decrease occurred in 2023, with NOPAT falling to US$3,292 million. This represents a substantial reduction of over 71% from the 2022 value. A recovery is then observed in 2024, with NOPAT rising to US$4,563 million, and continuing upward in 2025 to reach US$5,919 million. The 2025 value, while representing a significant improvement from 2023, remains below the levels seen in 2021 and 2022.

The divergence between the trends in net earnings and NOPAT suggests potential shifts in the company’s capital structure or non-operating items. While net earnings decreased significantly in 2023, the NOPAT decline was even more substantial, indicating that factors beyond core operating profitability contributed to the reduction in net income. The subsequent recovery in NOPAT, exceeding the recovery in net earnings, suggests improvements in operational efficiency or changes in the cost of capital may be influencing the results.

Relationship between NOPAT and Net Earnings

In 2021 and 2022, NOPAT was consistently higher than net earnings attributable to AbbVie Inc. However, this relationship changed in 2023 and 2024, where net earnings exceeded NOPAT. By 2025, net earnings and NOPAT were relatively close, but net earnings remained slightly higher. This difference could be attributed to items such as interest expense, taxes, and other non-operating income or expenses.

The substantial fluctuations in NOPAT warrant further investigation to understand the underlying drivers. A detailed analysis of the components of NOPAT, including operating revenue, operating expenses, and tax rates, would be necessary to pinpoint the specific factors contributing to these changes.

The reported income tax expense and cash operating taxes exhibit distinct trends over the five-year period. Income tax expense fluctuates considerably, while cash operating taxes generally increase, though with notable variations.

Income Tax Expense

Income tax expense increased from US$1,440 million in 2021 to US$1,632 million in 2022, representing a rise of approximately 13.3%. A subsequent decrease was observed in 2023, with expense falling to US$1,377 million. A significant shift occurred in 2024, resulting in a tax benefit of US$570 million. This was followed by a substantial increase in expense to US$2,364 million in 2025. The volatility suggests potential impacts from changes in tax laws, deferred tax asset adjustments, or significant shifts in pre-tax income.

Cash Operating Taxes

Cash operating taxes demonstrate an overall upward trend, although not consistently. The amount rose from US$2,843 million in 2021 to US$3,997 million in 2022, an increase of approximately 40.6%. Further growth was seen in 2023, reaching US$4,625 million. A considerable decline occurred in 2024, with cash taxes decreasing to US$1,339 million. The final year, 2025, shows a recovery to US$3,414 million. The fluctuations in cash taxes are likely influenced by timing differences between income tax expense and actual cash payments, as well as potential tax planning strategies.

Relationship between Income Tax Expense and Cash Operating Taxes

A divergence is apparent between the two measures. While income tax expense is reported on the income statement based on accounting standards, cash operating taxes reflect the actual cash outflows for taxes. The significant difference in 2024, where an income tax benefit is recorded alongside a cash outflow, indicates substantial deferred tax impacts or tax credits being utilized. The generally higher level of cash taxes compared to income tax expense throughout the period suggests the company may be utilizing tax loss carryforwards or experiencing temporary differences that result in higher cash payments than reported expense.

The observed patterns warrant further investigation into the underlying drivers of these fluctuations, particularly the significant changes in 2024 and 2025, to fully understand their implications for the company’s financial position and future cash flows.

The reported invested capital demonstrates a declining trend over the five-year period. Total reported debt & leases and stockholders’ equity both contribute to the calculation of invested capital, and changes in these components influence the overall trend.

Invested Capital Trend

Invested capital decreased from US$95,922 million in 2021 to US$61,356 million in 2025. The most significant decrease occurred between 2022 and 2023, falling from US$82,134 million to US$68,204 million. A smaller decrease was observed between 2021 and 2022. A slight increase occurred between 2023 and 2024, followed by a further decrease in 2025.

Debt & Leases

Total reported debt & leases decreased from US$77,575 million in 2021 to US$64,191 million in 2022, continuing to US$60,286 million in 2023. An increase to US$68,019 million was noted in 2024, followed by a marginal increase to US$68,379 million in 2025. While fluctuating, the level of debt remained relatively stable between 2024 and 2025.

Stockholders’ Equity

Stockholders’ equity increased from US$15,408 million in 2021 to US$17,254 million in 2022. However, a substantial decline was observed in subsequent years, decreasing to US$10,360 million in 2023, US$3,325 million in 2024, and ultimately reaching a deficit of US$-3,270 million in 2025. This negative equity position in the final year represents a significant shift.

The decrease in invested capital appears to be primarily driven by the substantial reduction in stockholders’ equity, particularly in the later years of the period. While debt levels decreased initially, they stabilized and even increased slightly in the most recent years, suggesting that debt reduction is not the primary driver of the overall decline in invested capital. The transition to negative stockholders’ equity in 2025 is a notable development that warrants further investigation.

The financial trajectory over the five-year period indicates a significant transition in value creation capabilities. After a period of positive economic performance in 2021 and 2022, the organization entered a phase of value destruction in 2023 and 2024, before returning to a positive, albeit marginal, economic profit by 2025.

Economic Spread Ratio

The economic spread ratio exhibited extreme volatility, peaking at 5.70% in 2022 before collapsing to -3.72% in 2023. This sharp reversal indicates that the return on invested capital fell below the cost of capital during the middle of the observed period. A gradual recovery is observed from 2023 through 2025, with the ratio climbing from -3.72% to 0.94%, signaling a return to positive economic value added.

Economic Profit

Economic profit mirrored the spread ratio's volatility. The initial positive contributions of US$ 4,853 million in 2021 and US$ 4,680 million in 2022 shifted to significant losses, reaching a trough of negative US$ 2,535 million in 2023. The subsequent improvement to negative US$ 1,387 million in 2024 and a return to a positive US$ 574 million in 2025 suggests a stabilization of operations and an improvement in the alignment of returns relative to capital costs.

Invested Capital

A consistent downward trend in invested capital is observed, decreasing from US$ 95,922 million in 2021 to US$ 61,356 million in 2025. This reduction represents a contraction of approximately 36% over the period. The decline in the capital base occurred concurrently with the period of value destruction, suggesting that capital reductions may have been a strategic response to declining economic spreads or the result of significant asset divestitures.

The synthesis of these metrics reveals that while the organization successfully returned to generating economic profit by 2025, the magnitude of value creation is substantially lower than the levels observed in 2021 and 2022. The recovery is characterized by a leaner capital structure and a modest positive economic spread.

The economic performance between 2021 and 2025 is characterized by a period of significant volatility, marked by a sharp contraction in value creation followed by a gradual recovery toward positive economic profit.

Economic Profit Margin Trends

A marked decline is observed from 2021 to 2023, with the economic profit margin falling from 8.64% to -4.67%. This transition indicates a shift from substantial value creation to a period where the cost of capital exceeded operating returns. A recovery phase began in 2024, as the margin improved to -2.46%, eventually returning to positive territory in 2025 at 0.94%.

Revenue and Profitability Correlation

Net revenues exhibited a fluctuating pattern, peaking at 61,160 million US$ in 2025. The most significant contraction in economic profit occurred in 2023, coinciding with a dip in net revenues to 54,318 million US$. While revenues recovered and grew in 2024 and 2025, the economic profit margin did not return to the levels seen in the 2021-2022 period, suggesting a change in the underlying cost structure or capital charges relative to revenue growth.

Value Restoration Analysis

The shift from an economic profit of -1,387 million US$ in 2024 to 574 million US$ in 2025 signifies a reversal of the value-destruction trend. However, the 2025 economic profit remains substantially lower than the 4,853 million US$ reported in 2021. This indicates that while the organization has restored its ability to generate economic value, the magnitude of that value creation is currently significantly diminished compared to historical benchmarks.